Therefore, we measured NfL and GFAP levels in the plasma and cerebrospinal fluid (CSF) of individuals with asymptomatic and symptomatic SCA7 and controls to evaluate their potential as disease biomarkers. The gene discussed is NEFL; the disease is spinocerebellar ataxia 7.